| SpectraBase Spectrum ID |
GsKp372qPzW |
| Name |
Diclazepam |
| Source of Sample |
Cayman Chemical Company |
| Catalog Number |
15554 |
| Lot Number |
0456870-1 |
| CAS Registry Number |
2894-68-0 |
| Classification |
benzodiazepine drug that produces psychoactive effects by enhancing signaling through the γ-aminobutyric acid (GABA) receptor GABAA |
| Compound Type |
Pure |
| Copyright |
Copyright © 2015-2024 John Wiley & Sons, Inc. All Rights Reserved. |
| Formula |
C16H12Cl2N2O |
| InChI |
InChI=1S/C16H12Cl2N2O/c1-20-14-7-6-10(17)8-12(14)16(19-9-15(20)21)11-4-2-3-5-13(11)18/h2-8H,9H2,1H3 |
| InChIKey |
VPAYQWRBBOGGPY-UHFFFAOYSA-N |
| Molecular Weight |
319.191 g/mol |
| Raman Corrections |
Referenced to internal white light source; 180 Degree backscatter |
| Raman Laser Source |
Nd:YAG |
| Source of Spectrum |
Forensic Spectral Research |
| Synonyms |
7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one; Ro 5-3448; 2'-Chlorodiazepam |
| Technique |
FT-Raman |
